Gene · 55600
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of visfatin and omentin-1 gene polymorphism in pancreatic ductal adenocarcinoma (PDAC). | Mol Biol Rep | 2025 | 40668426 | PubTator, text mining | PubMed |
| Omentin level in serum and gingival crevicular fluid following non-surgical periodontal therapy among Rheumatoid Arthritis patients. | Bioinformation | 2025 | 40636181 | PubTator, text mining | PubMed |
| Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis. | Biomol Biomed | 2025 | 40613523 | PubTator, text mining | PubMed |
| Endocrine consequences of childhood obesity: a narrative review. | Front Endocrinol (Lausanne) | 2025 | 40370785 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
| A robust pressure drop prediction model in vertical multiphase flow: a machine learning approach. | Sci Rep | 2025 | 40251204 | PubTator, text mining | PubMed |
| Pleiotropic role of mGluR7/MAPK signaling in the protection of intelectin-1 against cerebral ischemia-reperfusion injury. | Pharmacol Res | 2025 | 40250509 | PubTator, text mining | PubMed |
| Serum levels of omentin and visfatin in patients with metabolic syndrome. | Arch Physiol Biochem | 2025 | 40211898 | PubTator, text mining | PubMed |
| Seminal plasma proteomics of asymptomatic COVID-19 patients reveals disruption of male reproductive function. | BMC Genomics | 2025 | 40119256 | PubTator, text mining | PubMed |
| Effect of waterpipe smoking and its cessation on metabolic biomarkers and a novel biomarker omentin-1. | Biomarkers | 2025 | 40084921 | PubTator, text mining | PubMed |
| Single-cell and spatial analysis reveals the interaction between ITLN1+ foam cells and SPP1+ macrophages in atherosclerosis. | Front Cardiovasc Med | 2025 | 40017519 | PubTator, text mining | PubMed |
| High Intelectin-1 Expression Associated with Aggressive Tumor Behavior and Worse Survival in Rectal Cancer. | Onco Targets Ther | 2025 | 39830923 | PubTator, text mining | PubMed |
| Hypoxia and lipid metabolism related genes drive proliferation migration and immune infiltration mechanisms in colorectal cancer subtyping. | Sci Rep | 2025 | 39827204 | PubTator, text mining | PubMed |
| Gold(I) N-heterocyclic carbene complexes show strong proapoptotic, antioxidant and anti-inflammatory effects in A2780 and endothelial cells. | Chem Biol Interact | 2025 | 39824433 | PubTator, text mining | PubMed |
| Evaluation of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis, Omentin, and Tumor Necrosis Factor-α in Subjects with Periodontitis and Type 2 Diabetes Mellitus. | Genet Test Mol Biomarkers | 2025 | 39729310 | PubTator, text mining | PubMed |
| Omentin Increases Glucose Uptake, but Not Insulin Sensitivity in Human Myotubes Dependent on Extracellular Lactotransferrin. | Obes Facts | 2025 | 39527934 | PubTator, text mining | PubMed |
| Molecular Characterization and Expression of Lactoferrin Receptor (LfR) in Different Regions of the Brain Responding to Lactoferrin Intervention. | Mol Neurobiol | 2025 | 39179683 | PubTator, text mining | PubMed |
| Organic Moiety on Sn(IV) Does Matter for In Vitro Mode of Action: nBu3Sn(IV) Compounds with Carboxylato N-Functionalized 2-Quinolones Induce Anoikis-like Cell Death in A375 Cells. | Pharmaceutics | 2024 | 39771508 | PubTator, text mining | PubMed |
| Lactoferrin targeting INTL1 receptor inhibits hepatocellular carcinoma progression via apoptosis and cell cycle signaling pathways. | Sci Rep | 2024 | 39732873 | PubTator, text mining | PubMed |
| Biomarkers and Seaweed-Based Nutritional Interventions in Metabolic Syndrome: A Comprehensive Review. | Mar Drugs | 2024 | 39728125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55600/papers?page=5